The dopamine and cAMP regulated phosphoprotein, 32 kDa (DARPP-32) signaling pathway: A novel therapeutic target in traumatic brain injury
Authors:
- 1 June 2011
- journal article
- Published by Elsevier in Experimental Neurology
- Vol. 229 (2) , 300-307
Abstract
No abstract availableKeywords
Funding Information
- Ministry of Patriots and Veterans Affairs (B6761R)
This publication has 60 references indexed in Scilit:
- Persistent cognitive dysfunction after traumatic brain injury: A dopamine hypothesisNeuroscience & Biobehavioral Reviews, 2009
- Chronic methylphenidate treatment enhances striatal dopamine neurotransmission after experimental traumatic brain injuryJournal of Neurochemistry, 2009
- Cell type–specific regulation of DARPP-32 phosphorylation by psychostimulant and antipsychotic drugsNature Neuroscience, 2008
- The B″/PR72 subunit mediates Ca 2+ -dependent dephosphorylation of DARPP-32 by protein phosphatase 2AProceedings of the National Academy of Sciences, 2007
- Delayed increase of tyrosine hydroxylase expression in rat nigrostriatal system after traumatic brain injuryBrain Research, 2007
- DARPP-32 Is a Robust Integrator of Dopamine and Glutamate SignalsPLOS Computational Biology, 2006
- Bromocriptine Reduces Lipid Peroxidation and Enhances Spatial Learning and Hippocampal Neuron Survival in a Rodent Model of Focal Brain TraumaJournal of Neurotrauma, 2004
- Protein phosphatase 1 is a molecular constraint on learning and memoryNature, 2002
- Differential Subcellular Localization of Protein Phosphatase-1 α, γ1, and δ Isoforms during Both Interphase and Mitosis in Mammalian CellsJournal of Cell Biology, 1998
- Identification of PP1 Catalytic Subunit Isotypes PP1γ1, Pp1δ and Pp1α in Various Rat TissuesBiochemical and Biophysical Research Communications, 1993